ATLANTA, Jan. 24, 2019 /PRNewswire/ -- CorMatrix ® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced FDA approval of an early ...
ROSWELL, Ga.--(BUSINESS WIRE)--CorMatrix ® Cardiovascular, Inc. a leading developer of biomaterial compositions and medical devices for regenerative medicine, announced effective January 1, 2016 it ...
ROSWELL, Ga.CorMatrix® Cardiovascular Incorporated, a company specializing in its extracellular matrix (ECM®) technology announced today that it has received CE mark approval for its CorMatrix® ...
CorMatrix Cardiovascular has announced FDA 510(k) approval for its Tyke extracellular matrix biomaterial for use in neonates and infants. The company has created a patch that supports native tissue ...
ROSWELL, Ga., CorMatrix Cardiovascular, Inc., a leading developer of biomaterials and medical devices, today announced treatment of the first patient to receive their tissue engineered regenerative ...
ATLANTA, Aug. 5, 2020 /PRNewswire/ -- CorMatrix ® Cardiovascular, Inc., (www.cormatrix.com) a leading developer of regenerative biomaterial compositions and medical devices, today announced European ...
CorMatrix Cardiovascular Inc. has received three patents for a biomaterial heart valve. CorMatrix Cardiovascular Inc. has received three patents for a biomaterial heart valve. The Alpharetta biotech ...
NEW ORLEANS, Nov. 10 CorMatrix Cardiovascular, Inc., anAtlanta-based company dedicated to developing and delivering uniqueextracellular matrix (ECM(TM)) biomaterial devices that harness the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Roswell, Ga.-based medical device company CorMatrix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results